Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer?

Barbara Ingold, Eva Simon, Ute Ungethüm et al. · 2010

Read Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer? by Barbara Ingold, Eva Simon, Ute Ungethüm et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010087.txt.

Description

The authors were Barbara Ingold, Eva Simon, Ute Ungethüm, and others. Their 2010 PLOS ONE study hunted for new drug targets in stomach cancer. They focused on G-protein-coupled receptors, a large family of cell surface switches. Such receptors are strong candidates for cancer prevention and treatment strategies.

Comparing tumors that had spread to lymph nodes with those that had not, they singled out CXCR4. That receptor appeared in blood vessels feeding the cancer. Blocking it might slow new vessel growth, so the authors raise it as a possible antiangiogenic target.

Catalog record

CREATORBarbara Ingold, Eva Simon, Ute Ungethüm et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010087

Browse the full library · About the Tower of Babel